CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 20 enrolled
Drug / intervention
Kudzu +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01596231
NCT01596231Phase 2Completed
CompareCT.gov

Isoflavone (Kudzu) Extract Effects on Alcohol Drinking: Single Dose Pretreatment Study

Mclean Hospital·interventional·Posted May 10, 2012·Updated Oct 21, 2014

In Brief

A Phase 2 clinical trial evaluating Kudzu and Placebo for Alcohol Consumption. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This is a study designed to test whether a single administration of kudzu extract (2 mg) will significantly reduce the number of drinks consumed during a single 1 ½ hours drinking session when given as pretreatment 2 ½ hours before the drinking session.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Consumption
CountriesUnited States
CollaboratorsNational Institute on Alcohol Abuse and Alcoholism (NIAAA)

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 10, 2012
Enrollment StartMay 1, 2010
Primary CompletionMay 1, 2013
Study CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 14.1 years ago

Interventions

Kudzudietary

Kudzu (2 mg) will be administered as a pretreatment 2 ½ hours before a drinking session to see if it will significantly reduce the number of drinks consumed during a single 1 ½ hours drinking session.

Placebodietary

Placebo will be administered as a pretreatment 2 ½ hours before a drinking session